0001654954-17-009224.txt : 20171006 0001654954-17-009224.hdr.sgml : 20171006 20171006161109 ACCESSION NUMBER: 0001654954-17-009224 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171004 FILED AS OF DATE: 20171006 DATE AS OF CHANGE: 20171006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASELAGE STEVE CENTRAL INDEX KEY: 0001221599 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33004 FILM NUMBER: 171127337 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760333165 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE #2240 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE #2240 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 4 1 section16.xml FORM 4 X0306 4 2017-10-04 0001069308 Acer Therapeutics Inc. ACER 0001221599 ASELAGE STEVE C/O ACER THERAPEUTICS INC. 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 true Stock Option (right to buy) 15.34 2017-10-04 4 A false 6000 0 A 2027-10-04 Common Stock 6000 6000 D The option vests and becomes exercisable in full on October 4, 2018. /s/ Harry Palmin, Attorney-in-Fact 2017-10-06